David Budd to join Epistem as Chief Executive David Budd to join Epistem as Chief Executive He will start his new role by the middle of April CytRx appoints Olivia Ware as Chief Commercial Officer CytRx appoints Olivia Ware as Chief Commercial Officer Los Angeles-based firm specialises in oncology and is preparing for the results of a pivotal Phase III trial Gil Ben-Menachem becomes VP of Business Development Kitov Pharmaceuticals Gil Ben-Menachem becomes VP of Business Development Kitov Pharmaceuticals He previously held managerial and business development roles at Teva Pharmaceuticals and Dexcel Pharma Novavax appoints Jeffrey Stoddard as Vice President, Medical Affairs Novavax appoints Jeffrey Stoddard as Vice President, Medical Affairs He joins the firm with more than 15 years of vaccine research and development experience and leadership roles AMRI hires Senior Vice President to lead Active Pharmaceutical Ingredients Business AMRI hires Senior Vice President to lead Active Pharmaceutical Ingredients Business Dawn Von Rohr joins AMRI from Mallinckrodt Pharmaceuticals where she was VP and General Manager, Global APIs Paolo Paoletti joins PsiOxus Therapeutics at Chairman Paolo Paoletti joins PsiOxus Therapeutics at Chairman Former President of GSK Oncology adds depth of knowledge of cancer R&D Merck announces new biopharma heads for North America and China Merck announces new biopharma heads for North America and China Gary Zieziula and Marc Horn to head biopharma business in North America and China, respectively Adam Ryan Goodsell joins Business Development Team at Laurus Synthesis Adam Ryan Goodsell joins Business Development Team at Laurus Synthesis Will build sales in the Boston Biotech community Avacta hires Philippe Cotrel as Chief Commercial Officer Avacta hires Philippe Cotrel as Chief Commercial Officer Joins the UK firm from Abcam Averica Discovery appoints Cynthia Berger as Vice President of Operations Averica Discovery appoints Cynthia Berger as Vice President of Operations Will contribute broadly to the firm's growth and development Professor Graham Boulnois to become Chairman of the Medicines Technologies Catapult Professor Graham Boulnois to become Chairman of the Medicines Technologies Catapult The new Medicines Technologies Catapult at Alderley Park, Cheshire, UK, will support industry in developing new technologies primarily for the preclinical evaluation of medicines Recipharm appoints new Key Account Director for Europe Recipharm appoints new Key Account Director for Europe Anke Mollowitz is responsible for coordinating customer management and commercial aspects Remi Palmantier becomes Chief Scientific Officer at Genticel Remi Palmantier becomes Chief Scientific Officer at Genticel Will accelerate the discovery, development and integration of specific immunotherapies Chief Medical Officer Birgitte Volck to leave Sobi Chief Medical Officer Birgitte Volck to leave Sobi To join GlaxoSmithKline as Head of R&D Rare Diseases Ergomed makes changes to Board of Directors Ergomed makes changes to Board of Directors Neil Clark becomes CEO of PrimeVigilance, while Stephen Stamp is appointed as Chief Financial Officer of Ergomed Crown Bioscience hires Global Scientific Director for Translational Oncology Crown Bioscience hires Global Scientific Director for Translational Oncology Eric Murphy has focused on translational and drug discovery research for more than two decades